3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Head & Neck
1
Gastrointestinal
1
Conditions
Colorectal Neoplasms
8
Uterine Cervical Neoplasms
3
Breast Neoplasms
3
Pancreatic Neoplasms
2
Gastrointestinal Neoplasms
2
Esophageal Neoplasms
2
Urinary Bladder Neoplasms
1
Skin Neoplasms
1
Prostatic Neoplasms
1
Pancreatic carcinoma, familial
1
Pancreatic cancer, adult
1
Neoplasms
1
Neoplasm Metastasis
1
Lymphoma, Non-Hodgkin
1
Lung Neoplasms
1
Liver Neoplasms
1
Intestinal Neoplasms
1
Homosexuality
1
Hepatitis C
1
Head and Neck Neoplasms
1
HIV Infections
1
Fibrous Dysplasia, Polyostotic
1
Fibrous Dysplasia of Bone
1
Fibrosis
1
Endometrial Neoplasms
1
End Stage Liver Disease
1
Digestive System Neoplasms
1
Colonic Polyps
1
Colonic Neoplasms
1
Carcinoma, Hepatocellular
1
Interventions
pembrolizumab
29
Cetuximab
11
Nivolumab
10
Fluorouracil
8
Cyclophosphamide
8
Cisplatin
8
Carboplatin
8
fludarabine
7
atezolizumab
7
Blood Specimen Collection
7
cemiplimab
6
Radiotherapy
6
Drug Therapy
6
Immune Checkpoint Inhibitors
5
Gemcitabine
5
Paclitaxel
4
Docetaxel
4
Capecitabine
4
Biopsy
4
spartalizumab
3
avelumab
3
Surveys and Questionnaires
3
Pemetrexed
3
Oncolytic Virotherapy
3
Nicotine
3
Magnetic Resonance Spectroscopy
3
Irinotecan
3
Ipilimumab
3
Interleukin-2
3
Bortezomib
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Head and Neck Neoplasms
×
Mass Screening
×
Gastrointestinal
×
Clear all
NCT04379232
2020-05-07
SurgiCovid
Hospices Civils de Lyon
Completed
112 enrolled